Who ranks for “lung cancer clinical trials”

Major Areas of Current Research

Targeted Therapies: Trials are testing next-generation inhibitors for mutations like KRAS G12C, EGFR exon 20 insertions, HER2, and MET amplifications. Antibody-Drug Conjugates (ADCs): Delivering highly potent chemotherapy directly to tumor cells via targeted antibodies (such as trials evaluating TROP2- or B7-H3–targeted agents) is a rapidly expanding field. Immunotherapy Combinations: Studies are exploring dual checkpoint blockades or combining immunotherapy with anti-angiogenesis or chemotherapy to overcome treatment resistance.

Where to Find Open Trials

Search the official registry at ClinicalTrials.gov using filters for specific mutations, disease stage, and location. Review curated trial portfolios through the National Cancer Institute or the American Lung Association. Major academic medical centers and comprehensive cancer networks often host dedicated, site-specific trials (such as platform protocols like Lung-MAP or enterprise programs like the Gilead EDGE-Lung Trials ).

If you share the specific type of lung cancer (e.g., non-small cell vs. small cell), stage, and any known biomarker or genetic mutation results, I can help point you toward relevant trial categories or search strategies.